BamSEC and AlphaSense Join Forces
Learn More

Immix Biopharma Inc. – Indentures

NASDAQ: IMMX    
Share price (7/2/26): $10.34    
Market cap (7/2/26): $722 million

Indentures Filter

EX-4.7
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-3 30 pages Immix Biopharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20__ Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 30 pages Immix Biopharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20__ Senior Debt Securities
12/34/56
EX-4.1
from 8-K 10 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 13 pages Non-Transferrable Warrant to Purchase Common Stock
12/34/56
EX-4.4
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 2 pages Certificate of Ownership and Merger Merging Nexcella, Inc., a Delaware Corporation, With and Into Immix Biopharma, Inc., a Delaware Corporation
12/34/56
EX-4.1
from 8-K 14 pages Pre-Funded Warrant
12/34/56
EX-4.3
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-3 34 pages Immix Biopharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20__ Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 33 pages Immix Biopharma, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20__ Senior Debt Securities
12/34/56
EX-4.2
from S-1 18 pages Warrant to Purchase Common Stock Immix Biopharma, Inc
12/34/56
EX-4.3
from 10-K 2 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-1/A 20 pages Form of Representative’s Warrant Agreement
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56